Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 115
Filtrar
1.
Med Mycol ; 2024 Mar 13.
Artigo em Inglês | MEDLINE | ID: mdl-38479781

RESUMO

The National Reference Laboratory in Clinical Mycology of Argentina conducted a retrospective review of human coccidioidomycosis cases diagnosed by the National Mycology Laboratory Network of Argentina between 2010 and 2022 to determine the burden of the disease in the country. A total of 100 human coccidioidomycosis cases were documented, with a higher prevalence in male patients (male-to-female ratio of 1.9:1), with a median age of 41 years. Comparing the number of cases between two ten-year periods (2000-2009 and 2010-2019), the increase was 36.51% (from 63 to 86 cases). Among the 100 recorded cases, 79 tested positive using the double immunodiffusion test. Spherules were observed in 19 cases through histopathology or direct microscopic examination and the fungus was isolated in 39 cases. Thirty six isolates were identified as Coccidioides posadasii through partial sequencing of the Ag2/PRA gene. Catamarca Province had the highest number of cases, comprising 64% of the total, with an incidence rate above 1.0-2.5/100,000 inhabitants until 2018. However, there has been a recent downward trend in the region from 2018 to 2022. It is concerning that more than half of diagnosed cases were chronic pulmonary or disseminated forms, indicating a lack of early disease detection. To rectify this issue, it is imperative to conduct targeted training programs for healthcare personnel and enhance public awareness within the endemic area. This will contribute to a better understanding of the true burden of coccidioidomycosis and enable the implementation of appropriate sanitary control measures.


We conducted a retrospective review of human coccidioidomycosis cases in Argentina between 2010 and 2022. We recorded 100 cases, 64% of which came from Catamarca Province. A significant number of diagnosed cases were chronic pulmonary or disseminated forms, indicating a lack of early detection.

2.
Microorganisms ; 12(1)2024 Jan 20.
Artigo em Inglês | MEDLINE | ID: mdl-38276197

RESUMO

Emerging life-threatening multidrug-resistant (MDR) species such as the C. haemulonii species complex, Clavispora lusitaniae (sin. C. lusitaniae), and other Candida species are considered as an increasing risk for human health in the near future. (1) Background: Many studies have emphasized that the increase in drug resistance can be associated with several virulence factors in Candida and its knowledge is also essential in developing new antifungal strategies. (2) Methods: Hydrophobicity, adherence, biofilm formation, lipase activity, resistance to osmotic stress, and virulence 'in vivo' on G. mellonella larvae were studied in isolates of C. haemulonii, C. albicans, and C. lusitaniae with low susceptibility and resistance to fluconazole and amphotericin B. (3) Results: Intra- and interspecies variability were observed. C. haemulonii showed high hydrophobicity and the ability to adhere to and form biofilm. C. lusitaniae was less hydrophobic, was biofilm-formation-strain-dependent, and did not show lipase activity. Larvae inoculated with C. albicans isolates displayed significantly higher mortality rates than those infected with C. haemulonii and C. lusitaniae. (4) Conclusions: The ability to adhere to and form biofilms associated with their hydrophobic capacity, to adapt to stress, and to infect within an in vivo model, observed in these non-wild-type Candida and Clavispora isolates, shows their marked virulence features. Since factors that define virulence are related to the development of the resistance of these fungi to the few antifungals available for clinical use, differences in the physiology of these cells must be considered to develop new antifungal therapies.

3.
Expert Rev Anti Infect Ther ; 21(11): 1245-1257, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37883035

RESUMO

INTRODUCTION: Malassezia is a major component of the skin microbiome, a lipophilic symbiotic organism of the mammalian skin, which can switch to opportunistic pathogens triggering multiple dermatological disorders in humans and animals. This phenomenon is favored by endogenous and exogenous host predisposing factors, which may switch Malassezia from a commensal to a pathogenic phenotype. AREA COVERED: This review summarizes and discusses the most recent literature on the pathogenesis of Malassezia yeasts, which ultimately results in skin disorders with different clinical presentation. A literature search of Malassezia pathogenesis was performed via PubMed and Google scholar (up to May 2023), using the following keywords: Pathogenesis and Malassezia;host risk factors and Malassezia, Malassezia and skin disorders; Malassezia and virulence factors: Malassezia and metabolite production; Immunology and Malassezia. EXPERT OPINION: Malassezia yeasts can maintain skin homeostasis being part of the cutaneous mycobiota; however, when the environmental or host conditions change, these yeasts are endowed with a remarkable plasticity and adaptation by modifying their metabolism and thus contributing to the appearance or aggravation of human and animal skin disorders.


Assuntos
Malassezia , Dermatopatias Infecciosas , Animais , Humanos , Malassezia/genética , Malassezia/metabolismo , Pele , Fatores de Risco , Fenótipo , Mamíferos
4.
Expert Rev Anti Infect Ther ; 21(12): 1327-1338, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37883074

RESUMO

INTRODUCTION: Malassezia spp. are a group of lipid-dependent basidiomycetes yeasts acting as commensal organisms of the human and animal skin. However, under some not well-defined circumstances, these yeasts may switch to opportunistic pathogens triggering a number of skin disorders with different clinical presentations. The genus comprises of 18 lipid-dependent species with a variable distribution in the hosts and pathologies thus suggesting a host- and microbe-specific interactions. AREA COVERED: This review highlighted and discussed the most recent literature regarding the genus Malassezia as a commensal or pathogenic organisms highlighting Malassezia-associated skin disorders in humans and animals and their antifungal susceptibility profile. A literature search of Malassezia associated skin disorders was performed via PubMed and Google scholar (up to May 2023), using the different keywords mainly associated with Malassezia skin disorders and Malassezia antifungal resistance. EXPERT OPINION: Malassezia yeasts are part of the skin mycobiota and their life cycle is strictly associated with the environment in which they live. The biochemical, physiological, or immunological condition of the host skin selects Malassezia spp. or genotypes able to survive in a specific environment by changing their metabolisms, thus producing virulence factors or metabolites which can cause skin disorders with different clinical presentations.


Assuntos
Dermatite Seborreica , Dermatomicoses , Malassezia , Tinha Versicolor , Humanos , Animais , Tinha Versicolor/tratamento farmacológico , Tinha Versicolor/microbiologia , Tinha Versicolor/patologia , Dermatomicoses/tratamento farmacológico , Dermatomicoses/microbiologia , Antifúngicos/farmacologia , Antifúngicos/uso terapêutico , Dermatite Seborreica/tratamento farmacológico , Dermatite Seborreica/microbiologia , Pele/microbiologia , Pele/patologia , Lipídeos
5.
Biomedica ; 43(Sp. 1): 109-119, 2023 08 31.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-37721908

RESUMO

Introduction: Sporotrichosis is an implantation mycosis caused by Sporothrix spp. It is distributed worldwide and can be found in vegetation and soil. The most frequent route of infection is by trauma with elements contaminated with fungal propagules. Since domestic cats are the most affected animals and can transmit this infection to humans, sporotrichosis is considered a zoonosis. Clinical presentations include nodular lymphangitis, fixed cutaneous, pulmonary (rare), and disseminated (exceptional). Objectives: To analyze the epidemiology of sporotrichosis in Argentina during 2010 and 2022. To describe the clinical presentation, diagnostic methods, and treatment of cases diagnosed during this period. To know the circulating genotypes and to observe possible associations with the geographic location where the infection was acquired. Materials and methods: Analytical, retrospective, and observational study. We analyzed the medical records of patients with sporotrichosis from 12 health institutions in Argentina, between 2010 and 2022. Results: We present 54 cases in which the most frequent clinical form was nodular lymphangitis, and the treatment of choice was itraconazole. Conventional diagnosis was made in all cases. Culture of clinical samples was more sensitive than direct examination because it allowed the isolation of Sporothrix spp. in all 54 cases. Molecular identification was performed in 22 cases, with Sporothrix schenkii sensu stricto being the most frequently isolated species. Conclusions: This study allowed to know the epidemiology of this mycosis in Argentina, as well as the availability of diagnostic methods and the treatment of choice.


Introducción: La esporotricosis es una micosis de implantación causada por Sporothrix spp. Este se encuentra distribuido mundialmente y se puede encontrar en la vegetación y en el suelo. La ruta más frecuente de adquisición de la infección es por traumatismos con elementos contaminados con propágulos del hongo. Los gatos domésticos son los animales más afectados y pueden transmitirla a los humanos, por lo que es considerada una zoonosis. Las formas clínicas incluyen: la linfangítica nodular, la cutánea fija, la pulmonar (poco habitual) y la diseminada (excepcional). Objetivo: Analizar la epidemiología de la esporotricosis en Argentina entre los años 2010 y 2022. Describir la presentación clínica, los métodos de diagnóstico y el tratamiento de los casos diagnosticados en este período. Conocer los genotipos circulantes y observar su relación con el lugar geográfico de adquisición de la infección. Materiales y métodos. Se llevó a cabo un estudio analítico, retrospectivo y observacional, en el que se analizaron las historias clínicas de los pacientes con esporotricosis de 12 instituciones de salud de Argentina, entre los años 2010 y 2022. Resultados: Se presentan 54 casos en los que la forma clínica más frecuente fue la linfangítica nodular y el tratamiento de elección fue el itraconazol. En todos los casos se realizó diagnóstico convencional. El cultivo de las muestras clínicas resultó más sensible que el examen directo, ya que permitió el desarrollo de Sporothrix spp. en los 54 casos. En 22 casos se hizo identificación molecular y Sporothrix schenkii sensu stricto fue la especie más frecuentemente aislada. Conclusiones: Este estudio permitió conocer la epidemiología de esta micosis en Argentina, así como la disponibilidad de métodos diagnósticos y el tratamiento de elección.


Assuntos
Itraconazol , Tolnaftato , Animais , Argentina/epidemiologia , Zoonoses
6.
Biomédica (Bogotá) ; 43(Supl. 1): 109-119, ago. 2023. tab, graf
Artigo em Espanhol | LILACS | ID: biblio-1533882

RESUMO

Introducción. La esporotricosis es una micosis de implantación causada por Sporothrix spp. Este se encuentra distribuido mundialmente y se puede encontrar en la vegetación y en el suelo. La ruta más frecuente de adquisición de la infección es por traumatismos con elementos contaminados con propágulos del hongo. Los gatos domésticos son los animales más afectados y pueden transmitirla a los humanos, por lo que es considerada una zoonosis. Las formas clínicas incluyen: la linfangítica nodular, la cutánea fija, la pulmonar (poco habitual) y la diseminada (excepcional). Objetivo. Analizar la epidemiología de la esporotricosis en Argentina entre los años 2010 y 2022. Describir la presentación clínica, los métodos de diagnóstico y el tratamiento de los casos diagnosticados en este período. Conocer los genotipos circulantes y observar su relación con el lugar geográfico de adquisición de la infección. Materiales y métodos. Se llevó a cabo un estudio analítico, retrospectivo y observacional, en el que se analizaron las historias clínicas de los pacientes con esporotricosis de 12 instituciones de salud de Argentina, entre los años 2010 y 2022. Resultados. Se presentan 54 casos en los que la forma clínica más frecuente fue la linfangítica nodular y el tratamiento de elección fue el itraconazol. En todos los casos se realizó diagnóstico convencional. El cultivo de las muestras clínicas resultó más sensible que el examen directo, ya que permitió el desarrollo de Sporothrix spp. en los 54 casos. En 22 casos se hizo identificación molecular y Sporothrix schenkii sensu stricto fue la especie más frecuentemente aislada. Conclusiones. Este estudio permitió conocer la epidemiología de esta micosis en Argentina, así como la disponibilidad de métodos diagnósticos y el tratamiento de elección.


Introduction. Sporotrichosis is an implantation mycosis caused by Sporothrix spp. It is distributed worldwide and can be found in vegetation and soil. The most frequent route of infection is by trauma with elements contaminated with fungal propagules. Since domestic cats are the most affected animals and can transmit this infection to humans, sporotrichosis is considered a zoonosis. Clinical presentations include nodular lymphangitis, fixed cutaneous, pulmonary (rare), and disseminated (exceptional). Objective. To analyze the epidemiology of sporotrichosis in Argentina during 2010 and 2022. To describe the clinical presentation, diagnostic methods, and treatment of cases diagnosed during this period. To know the circulating genotypes and to observe possible associations with the geographic location where the infection was acquired. Materials and methods. Analytical, retrospective, and observational study. We analyzed the medical records of patients with sporotrichosis from 12 health institutions in Argentina, between 2010 and 2022. Results. We present 54 cases in which the most frequent clinical form was nodular lymphangitis, and the treatment of choice was itraconazole. Conventional diagnosis was made in all cases. Culture of clinical samples was more sensitive than direct examination because it allowed the isolation of Sporothrix spp. in all 54 cases. Molecular identification was performed in 22 cases, with Sporothrix schenkii sensu stricto being the most frequently isolated species. Conclusions. This study allowed to know the epidemiology of this mycosis in Argentina, as well as the availability of diagnostic methods and the treatment of choice.


Assuntos
Esporotricose , Argentina , Sporothrix , Micoses
7.
J Fungi (Basel) ; 9(4)2023 Apr 17.
Artigo em Inglês | MEDLINE | ID: mdl-37108936

RESUMO

Information on paracoccidioidomycosis (PCM) in Argentina is fragmented and has historically been based on estimates, supported only by a series of a few reported cases. Considering the lack of global information, a national multicentric study in order to carry out a more comprehensive analysis was warranted. We present a data analysis including demographic and clinical aspects of a historical series of 466 cases recorded over 10 years (2012-2021). Patients were aged from 1 to 89 years. The general male: female (M:F) ratio was 9.5:1 with significant variation according to the age group. Interestingly, the age range 21-30 shows an M:F ratio of 2:1. Most of the cases (86%) were registered in northeast Argentina (NEA), showing hyperendemic areas in Chaco province with more than 2 cases per 10,000 inhabitants. The chronic clinical form occurred in 85.6% of cases and the acute/subacute form occurred in 14.4% of cases, but most of these juvenile type cases occurred in northwestern Argentina (NWA). In NEA, the incidence of the chronic form was 90.6%; in NWA, the acute/subacute form exceeded 37%. Diagnosis by microscopy showed 96% positivity but antibody detection displays 17% of false negatives. Tuberculosis was the most frequent comorbidity, but a diverse spectrum of bacterial, fungal, viral, parasitic, and other non-infectious comorbidities was recorded. This national multicenter registry was launched in order to better understand the current status of PCM in Argentina and shows the two endemic zones with a highly diverse epidemiology.

8.
Med Mycol ; 61(3)2023 Mar 02.
Artigo em Inglês | MEDLINE | ID: mdl-36958865

RESUMO

Malassezia sympodialis and Malassezia furfur are recognized as an important part of the human and animals healthy skin microbiota, but also as an opportunistic fungus due to their association with a broad spectrum of skin and systemic infections. Human skin infections associated with Malassezia spp. are often chronic, recurrent, and topical or oral azole treatments are challenging with not always successful outcomes. A wide inter and intraspecies antifungal susceptibility variability that may suggest a combination of wild-type strains and resistant mutants was reported. The essential oils are complex hydrophobic mixtures of different compounds extracted from plants by distillation and have demonstrated antimicrobial activity. In this study, toxicity in the larvae model and the ability of Origanum vulgare essential oil (OVEO) and carvacrol to inhibit virulence factors such as hydrophobicity, adherence, and biofilm formation of M. sympodialis and M. furfur was evaluated. We have demonstrated the antifungal activity of OVEO and carvacrol against both species. Carvacrol was more active and less toxic than OVEO at low concentrations (< 1 mg/ml). Malassezia sympodialis showed a significant decrease in adherence and its ability to form biofilms when OVEO or carvacrol is present. Both Malassezia species showed reduced hydrophobicity in the presence of carvacrol. Further studies will have to be carried out to understand how these substances act, but the inhibition of some virulence factors could represent a new target to overcome the problem of drug resistance.


The work reports the research on the effect of the Origanum vulgare essential oil and carvacrol, against virulence factors such as hydrophobicity, adherence, and biofilm formation of two species of Malassezia. The inhibition of virulence factors could represent a new target to overcome the drug resistance reported.


Assuntos
Malassezia , Óleos Voláteis , Origanum , Humanos , Animais , Óleos Voláteis/farmacologia , Óleos Voláteis/química , Antifúngicos/farmacologia , Origanum/química , Fatores de Virulência
9.
Rev. odontopediatr. latinoam ; 13: 222523, 2023. ilus, tab
Artigo em Espanhol | LILACS, COLNAL | ID: biblio-1428324

RESUMO

Objetivo: Comparar, la efectividad clínica y microbiológica, entre las técnicas de eliminación tradicional y químico-mecánicas, para el tratamiento de lesiones cavitadas abiertas no penetrantes en dientes primarios en niños de 4 a 8 años, analizándose 57 dientes primarios. Grupo I: técnica tradicional (19 piezas), Grupo II: Brix (18 piezas), Grupo III: Papacarie (20 piezas). Evaluación clínica (necesidad de anestesiar y tiempo de ejecución) los datos fueron asentados en cada historia clínica. Antes y después del procedimiento operatorio, se tomaron muestras de la cavidad con microbrush estéril, transportándolas en tioglicolato para analizar cuantitativamente el total de bacterias presente por mililitro, utilizando cultivos de agar sangre (base Columbia). La información fue tabulada y analizada estadísticamente mediante Análisis de la Variancia, pruebas de Tukey y de Chi Cuadrado, estableciéndose como criterio de significancia p≤0.05. La diferencia significativa en la cantidad de bacterias entre el grupo I (41.22 ± 4.45) y los grupos II y III (65.96 ± 4.33, 83.45 ± 4.57), reveló que el grupo I fue menos efectivo. En los grupos II y III no se requirió la utilización de anestesia, siendo significativa la diferencia en los niños de edad preescolar (4 y 5 años). El tiempo de ejecución para cada técnica manifestó mayor rapidez en el grupo I (2.12 min ± 0.15) p˂0.0001. Las técnicas que utilizan algún agente químico permiten una mayor eliminación de bacterias durante la remoción de tejido cariado, sin recurrir a anestesia, por lo que pueden ser recomendadas como alternativa al tratamiento tradicional especialmente en niños pequeños.


Objetivo. Este estudo pretende comparar a eficácia clínica e microbiológica de três técnicas para a eliminação do tecido cariado, em crianças dos 4 aos 8 anos. Materiais e Método. Cinquenta e sete dentes decíduos foram analisados. Grupo I: técnica tradicional (19 dentes), Grupo II: Brix (18 dentes), Grupo III: Papacarie (20 dentes). Os dados para avaliação clínica (necessidade de anestesia e tempo de execução) foram registrados em cada anamnese. Antes e após o procedimento operatório, foram retiradas amostras da lesão cariosa com microbrush estéril, transportadas em tioglicolato para análise quantitativa do total de bactérias presentes por mililitro, utilizando culturas de ágar sangue (base Columbia). A informaçâo foi tabulada e analisada estatisticamente por meio do Analize da Varianza, testes de Tukey e do Qui-Quadrado, estabelecendo-se p≤0.05 como critério de significância. Resultados. A diferença na cantidade de bactérias entre o grupo I (41.22 ± 4.45), II e III (65.96 ± 4.33, 83.45 ± 4.57), revelou que o grupo I foi menos eficaz. Os grupos II e III não necessitaram do uso de anestesia, sendo a diferença significativa no grupo de pré-escolares (4 e 5 anos). O tempo de execução de cada técnica foi mais rápido no grupo I (2.12 min ± 0.15) p˂0.0001. Conclusão. As técnicas que utilizam algum agente químico permitem uma maior eliminação de bactérias durante a remoção do tecido cariado, sem recorrer à anestesia, podendo ser recomendadas como alternativa ao tratamento tradicional, especialmente em crianças pequenas.


Aim. This study pretends to compare the clinical and microbiological effectiveness of three techniques for the elimination of carious tissue in children aged 4 to 8 years old. Methods. Fifty-seven primary teeth were analyzed. Group I: traditional technique (19 teeth), Group II: Brix (18 teeth), Group III: Papacarie (20 teeth). The data for clinical evaluation (need for anesthesia and running time) were recorded in each case history. Before and after the operative procedure, samples were taken from the carious lesion with sterile micro brush, transported in thioglycollate to quantitatively analyze the total bacteria present per milliliter, using blood agar cultures (Columbia base). Information was tabulated and statistically analyzed using Analysis of Variance, Tukey's and Chi Square tests, establishing p≤0.05 as the criterion of significance. Results. The difference on number of bacteria between group I (41.22 ± 4.45), and groups II and III (65.96 ± 4.33, 83.45 ± 4.57), revealed that group I was less effective. Groups II and III did not require the use of anesthesia, the difference being significant in the group of pre-school children (4 and 5 years old). The execution time for each technique was faster in group I (2.12 min ± 0.15) p˂0.0001. Conclusions. Techniques that use some chemical agents allow a greater elimination of bacteria during the removal of carious tissue, without resorting to anesthesia, can be recommended as an alternative to traditional treatment especially in young children.


Assuntos
Humanos , Pré-Escolar , Criança , Compostos Químicos , Cárie Dentária , Instrumentos Odontológicos , Procedimentos Cirúrgicos Operatórios , Efetividade , Resultado do Tratamento
10.
Front Chem ; 10: 1023542, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-36277355

RESUMO

In recent years, an increase in multidrug-resistant fungal strains has been observed, which, together with the limited number of clinically available antifungal agents, highlights the need for the development of new antifungal agents. Due to the proven antifungal activity of silver nanoparticles (AgNPs), there is a growing interest in their use in the treatment of fungal infections. Nanoparticles are usually synthesised through a variety of physical and chemical processes that are costly and pollute the environment. For this reason, biogenic synthesis is emerging as an environmentally friendly technology and new strategies are increasingly based on the use of biogenic AgNPs as antifungal agents for clinical use. The aim of this review is to compare the antifungal activity of different biogenic AgNPs and to summarise the current knowledge on the mechanisms of action and resistance of fungi to AgNPs. Finally, a general analysis of the toxicity of biogenic AgNPs in human and veterinary medicine is performed.

11.
Mycoses ; 65(12): 1179-1187, 2022 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-35971917

RESUMO

BACKGROUND: The Americas are home to biologically and clinically diverse endemic fungi, including Blastomyces, Coccidioides, Emergomyces, Histoplasma, Paracoccidioides and Sporothrix. In endemic areas with high risk of infection, these fungal pathogens represent an important public health problem. OBJECTIVES: This report aims to summarise the main findings of the regional analysis carried out on the status of the endemic mycoses of the Americas, done at the first International Meeting on Endemic Mycoses of the Americas (IMEMA). METHODS: A regional analysis for the Americas was done, the 27 territories were grouped into nine regions. A SWOT analysis was done. RESULTS: All territories reported availability of microscopy. Seventy percent of territories reported antibody testing, 67% of territories reported availability of Histoplasma antigen testing. None of the territories reported the use of (1-3)-ß-d-glucan. Fifty two percent of territories reported the availability of PCR testing in reference centres (mostly for histoplasmosis). Most of the territories reported access to medications such as trimethoprim-sulfamethoxazole, itraconazole, voriconazole and amphotericin B (AMB) deoxycholate. Many countries had limited access to liposomal formulation of AMB and newer azoles, such as posaconazole and isavuconazole. Surveillance of these fungal diseases was minimal. CONCLUSIONS: A consensus emerged among meeting participants, this group concluded that endemic mycoses are neglected diseases, and due to their severity and lack of resources, the improvement of diagnosis, treatment and surveillance is needed.


Assuntos
Histoplasmose , Micoses , Humanos , Antifúngicos/uso terapêutico , Micoses/diagnóstico , Micoses/tratamento farmacológico , Micoses/epidemiologia , Itraconazol/uso terapêutico , Histoplasma , Histoplasmose/diagnóstico , Histoplasmose/tratamento farmacológico , Histoplasmose/epidemiologia , América/epidemiologia
12.
Med Mycol ; 60(8)2022 Aug 08.
Artigo em Inglês | MEDLINE | ID: mdl-35772016

RESUMO

Malassezia are common yeasts in human skin microbiome. Under certain conditions these yeasts may cause disease from skin disorders to systemic infections. In the absence of clinical breakpoints, epidemiological cutoff values (ECVs) are useful to differentiate isolates with acquired or mutational resistance. The aim of this work was to propose tentative ECVs of Malassezia furfur, M. sympodialis, M. globosa for fluconazole (FCZ), itraconazole (ITZ), voriconazole (VCZ), ketoconazole (KTZ) and amphotericin B (AMB). A total of 160 isolates (80 M. furfur, 50 M. sympodialis, and 30 M. globosa) were tested. Minimal inhibitory concentrations (MICs) were determined by modified broth microdilution method (CLSI). ECVs were estimated by ECOFFinder software and twofold dilutions beyond the mode. ITZ, KTZ, and VCZ showed the lowest MICs. The highest MIC and widest ranges were for FCZ and AMB. For ITZ, KTZ, and VCZ both ECVs were similar. For FCZ, AMB especially M. furfur, modal ECVs were lower than values obtained by statistical method. When MIC distribution is the only data available, ECV could provide information to help guide therapy decisions. In that drug/species combination in which different peaks in the MIC distribution were observed, difference between both ECV was greater. This is the first study that provides ECV data of 160 Malassezia yeasts. Although ECVs cannot be used as predictors of clinical response, identification of non wild-type isolates suggests that it may be less likely to respond to a given antifungal agent. LAY SUMMARY: Malassezia species causes skin disorders to systemic infections. Epidemiological cutoff value (ECV) allows for differentiation of wild-type and non wild-type isolates. Based on MIC data of 160 isolates we propose tentative ECVs for three Malassezia species. ECVs are useful in surveillance and guide therapy decisions.


Assuntos
Malassezia , Anfotericina B/farmacologia , Animais , Antifúngicos/farmacologia , Fluconazol/farmacologia , Humanos , Itraconazol/farmacologia , Cetoconazol/farmacologia , Testes de Sensibilidade Microbiana/veterinária , Voriconazol/farmacologia
13.
Med Mycol ; 60(5)2022 May 18.
Artigo em Inglês | MEDLINE | ID: mdl-35394043

RESUMO

COVID-19-associated pulmonary aspergillosis (CAPA) incidence varies depending on the country. Serum galactomannan quantification is a promising diagnostic tool since samples are easy to obtain with low biosafety issues. A multicenter prospective study was performed to evaluate the CAPA incidence in Argentina and to assess the performance of the lateral flow assay with digital readout (Sona Aspergillus LFA) as a CAPA diagnostic and screening tool. The correlation between the values obtained with Sona Aspergillus LFA and Platelia® EIA was evaluated. In total, 578 serum samples were obtained from 185 critically ill COVID patients. CAPA screening was done weekly starting from the first week of ICU stay. Probable CAPA incidence in critically ill patients was 10.27% (19/185 patients when LFA was used as mycological criteria) and 9% (9/100 patients when EIA was used as mycological criteria). We found a very good correlation between the two evaluated galactomannan quantification methods (overall agreement of 92.16% with a Kappa statistic value of 0.721). CAPA diagnosis (>0.5 readouts in LFA) were done during the first week of ICU stay in 94.7% of the probable CAPA patients. The overall mortality was 36.21%. CAPA patients' mortality and length of ICU stay were not statistically different from for COVID (non-CAPA) patients (42.11 vs 33.13% and 29 vs 24 days, respectively). These indicators were lower than in other reports. LFA-IMMY with digital readout is a reliable tool for early diagnosis of CAPA using serum samples in critically ill COVID patients. It has a good agreement with Platelia® EIA. LAY SUMMARY: The incidence of COVID-associated pulmonary aspergillosis (CAPA) in critically-ill Argentinian patients was established (10.27%). Serum galactomannan quantification was useful as a screening tool for this mycosis. A good agreement between Platelia® EIA and Sona Aspergillus LFA is reported.


Assuntos
COVID-19 , Aspergilose Pulmonar Invasiva , Aspergilose Pulmonar , Animais , Argentina/epidemiologia , Aspergillus , COVID-19/diagnóstico , COVID-19/veterinária , Estado Terminal , Galactose/análogos & derivados , Humanos , Aspergilose Pulmonar Invasiva/diagnóstico , Aspergilose Pulmonar Invasiva/veterinária , Mananas , Estudos Prospectivos , Aspergilose Pulmonar/diagnóstico , Aspergilose Pulmonar/veterinária , Sensibilidade e Especificidade
14.
Rev. argent. microbiol ; 54(1): 1-10, mar. 2022. graf
Artigo em Espanhol | LILACS-Express | LILACS | ID: biblio-1407161

RESUMO

Resumen Evaluamos las concordancias interlaboratorio, esencial y categórica entre el panel Sensititre YeastOne™ y los métodos de referencia correspondientes al M27 4.a ed. (Clinical and Laboratory Standards Institute [CLSI]) y al EDef 7.3.1 (European Committee on Antifungal Susceptibility Testing [EUCAST]). Estudiamos 67 cepas de Candida de distintas muestras clí nicas y un panel de 9 cepas resistentes a fluconazol y equinocandinas. El mayor porcentaje de concordancia interlaboratorio se observó con anfotericina B (96,8%) y el menor porcen taje con voriconazol (77,2%). La caspofungina mostró un 5,8% de discrepancias muy mayores con el método de referencia del CLSI. Con el del EUCAST, el itraconazol, el posaconazol y la anidulafungina mostraron porcentajes de discrepancias mayores: el 17,6, el 18,1 y el 19,6%, respectivamente. El panel Sensititre YeastOne™ es una alternativa confiable y fácil de usar, que permite detectar especies de Candida resistentes a los antifúngicos, con algunas limitaciones para las equinocandinas. Los resultados son equiparables a los de los métodos de referencia.


Abstract We evaluated the interlaboratory agreement, the essential agreement, and the cate- gorical agreement between the Sensititre YeastOne™ panel and the reference methods M27 4th Edition of the Clinical and Laboratory Standards Institute (CLSI), and the EDef 7.3.1 of the Euro- pean Committee on Antifungal Susceptibility Testing (EUCAST). We studied 67 Candida strains isolated from different clinical samples and 9 Candida strains with resistance to fluconazole and echinocandins. The highest percentage of interlaboratory agreement was observed with amp- hotericin B (96.8%), and the lowest percentage with voriconazole (77.2%). Caspofungin showed 5.8% of very major errors when compared with the CLSI reference method. For EUCAST, itraconazole, posaconazole, and anidulafungin showed high percentages of major errors: 17.6%, 18.1%, and 19.6%, respectively. Sensititre YeastOne™ is a reliable alternative, and easy to perform for detecting Candida species resistant to antifungal drugs, with some limitations for echinocandins. Results are comparable to those of the reference methods.

15.
Med Mycol Case Rep ; 35: 26-29, 2022 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-35059283

RESUMO

The genus Lichtheimia is the third-most frequent genus isolated in mucormycosis. We report a cutaneous case caused by Lichtheimia ramosa, localized on the face of a pediatric patient, in the context of acute liver failure and caloric malnutrition. Several surgeries and treatment with liposomal amphotericin B enabled the patient's favorable evolution.

16.
Rev Argent Microbiol ; 54(1): 9-14, 2022.
Artigo em Espanhol | MEDLINE | ID: mdl-33875292

RESUMO

We evaluated the interlaboratory agreement, the essential agreement, and the categorical agreement between the Sensititre YeastOneTM panel and the reference methods M27 4th Edition of the Clinical and Laboratory Standards Institute (CLSI), and the EDef 7.3.1 of the European Committee on Antifungal Susceptibility Testing (EUCAST). We studied 67 Candida strains isolated from different clinical samples and 9 Candida strains with resistance to fluconazole and echinocandins. The highest percentage of interlaboratory agreement was observed with amphotericin B (96.8%), and the lowest percentage with voriconazole (77.2%). Caspofungin showed 5.8% of very major errors when compared with the CLSI reference method. For EUCAST, itraconazole, posaconazole, and anidulafungin showed high percentages of major errors: 17.6%, 18.1%, and 19.6%, respectively. Sensititre YeastOneTM is a reliable alternative, and easy to perform for detecting Candida species resistant to antifungal drugs, with some limitations for echinocandins. Results are comparable to those of the reference methods.


Assuntos
Candida , Candidíase , Antifúngicos/farmacologia , Candidíase/microbiologia , Equinocandinas , Humanos , Testes de Sensibilidade Microbiana
17.
Sci Rep ; 11(1): 14566, 2021 07 15.
Artigo em Inglês | MEDLINE | ID: mdl-34267298

RESUMO

Combining traditional medicine with nanotechnology therefore opens the door to innovative strategies for treating skin and soft tissue infections (SSTIs) and also contributes to the fight against the rise of antimicrobial resistance. Acanthospermum australe (Loefl.) Kuntze is a medicinal plant used by indigenous peoples in northeastern Argentina to treat SSTIs. Spherical and stable silver nanoparticles (AgNPs) of 14 ± 2 nm were synthesized from the aqueous extract of A. australe and silver nitrate. The antimicrobial activity against main species causing SSTIs and cytotoxicity on peripheral blood mononuclear cells of AgNP solution and its synthesis components were evaluated. Compared to its synthesis components, AgNP solution showed greater antimicrobial activity and lower cytotoxicity. The antimicrobial activity of AgNPs was due to the silver and not to the metabolites of the aqueous extract present on the surface of the nanoparticles. The plant extract played an important role in the formation of stable AgNPs and acted as a modulator of cytotoxic and immune responses.


Assuntos
Anti-Infecciosos/farmacologia , Nanopartículas Metálicas/química , Prata/química , Dermatopatias Infecciosas/microbiologia , Infecções dos Tecidos Moles/microbiologia , Anti-Infecciosos/síntese química , Antioxidantes/química , Antioxidantes/farmacologia , Asteraceae/química , Flavonoides/análise , Química Verde , Humanos , Leucócitos Mononucleares/efeitos dos fármacos , Nanopartículas Metálicas/uso terapêutico , Testes de Sensibilidade Microbiana , Fenóis/análise , Extratos Vegetais/química
18.
Fungal Genet Biol ; 140: 103395, 2020 07.
Artigo em Inglês | MEDLINE | ID: mdl-32325168

RESUMO

Paracoccidioidomycosis (PCM) is a life-threatening systemic mycosis widely reported in the Gran Chaco ecosystem. The disease is caused by different species from the genus Paracoccidioides, which are all endemic to South and Central America. Here, we sequenced and analyzed 31 isolates of Paracoccidioides across South America, with particular focus on isolates from Argentina and Paraguay. The de novo sequenced isolates were compared with publicly available genomes. Phylogenetics and population genomics revealed that PCM in Argentina and Paraguay is caused by three distinct Paracoccidioides genotypes, P. brasiliensis (S1a and S1b) and P. restrepiensis (PS3). P. brasiliensis S1a isolates from Argentina are frequently associated with chronic forms of the disease. Our results suggest the existence of extensive molecular polymorphism among Paracoccidioides species, and provide a framework to begin to dissect the connection between genotypic differences in the pathogen and the clinical outcomes of the disease.


Assuntos
Variação Genética/genética , Genômica , Paracoccidioides/genética , Paracoccidioidomicose/genética , Argentina/epidemiologia , Ecossistema , Genética Populacional , Genoma Fúngico/genética , Genótipo , Humanos , Paracoccidioides/classificação , Paracoccidioides/patogenicidade , Paracoccidioidomicose/classificação , Paracoccidioidomicose/epidemiologia , Paracoccidioidomicose/microbiologia , Paraguai/epidemiologia , Filogenia
19.
Med Mycol ; 58(8): 1162-1168, 2020 Nov 10.
Artigo em Inglês | MEDLINE | ID: mdl-32242627

RESUMO

The genus Malassezia comprises a heterogeneous group of species that cause similar pathologies. Malassezia yeasts were considered as the most abundant skin eukaryotes of the total skin mycobiome. The ability of this fungus to colonize or infect is determined by complex interactions between the fungal cell and its virulence factors. This study aims to evaluate in vitro the hydrophobicity levels, the adherence capacity on a polystyrene surface and the ability to form biofilm of 19 isolates, including M. sympodialis, M. globosa, and M. slooffiae, from healthy subjects and from dermatological disorders. Cellular surface hydrophobicity levels were determined by two-phase system. The biofilm formation was determined by tetrazolium salt (XTT) reduction assay and by Scanning Electron Microscopy (SEM). Strain dependence was observed in all virulence factors studied. All isolates of M. sympodialis, M. globosa, and M. slooffiae demonstrated their ability to form biofilm at variable capacities. SEM observations confirmed a variable extracellular matrix after 48 hours of biofilm formation. All isolates of M. globosa were highly adherent and/or hydrophobic as well as biofilm producers. In contrast, M. slooffiae was the least biofilm producer. No significant differences between virulence factors were demonstrated for M. sympodialis, either as clinical isolate or as inhabitant of human microbiota. Results of this work together with the previous M. furfur research confirm that the most frequently Malassezia species isolated from normal subject's skin and patients with dermatosis, form biofilm with different capacities. The study of these virulence factors is important to highlight differences between Malassezia species and to determine their involvement in pathological processes.


Assuntos
Biofilmes/crescimento & desenvolvimento , Dermatomicoses/microbiologia , Malassezia/fisiologia , Pele/microbiologia , Adesão Celular , Humanos , Interações Hidrofóbicas e Hidrofílicas , Malassezia/classificação , Malassezia/isolamento & purificação , Especificidade da Espécie , Fatores de Virulência
20.
Front Cell Infect Microbiol ; 10: 605679, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-33680980

RESUMO

Paracoccidioidomycosis (PCM) is the most relevant systemic endemic mycosis limited to Latin American countries. The etiological agents are thermally dimorphic species of the genus Paracoccidioides. Infection occurs via respiratory tract by inhalation of propagules from the environmental (saprophytic) phase. In the lung alveoli the fungus converts to the characteristic yeast phase (parasitic) where interact with extracellular matrix proteins, epithelial cells, and the host cellular immunity. The response involves phagocytic cells recognition but intracellular Paracoccidioides have demonstrated the ability to survive and also multiply inside the neutrophils, macrophages, giant cells, and dendritic cells. Persistence of Paracoccidioides as facultative intracellular pathogen is important in terms of the fungal load but also regarding to the possibility to disseminate penetrating other tissues even protected by the phagocytes. This strategy to invade other organs via transmigration of infected phagocytes is called Trojan horse mechanism and it was also described for other fungi and considered a factor of pathogenicity. This mini review comprises a literature revision of the spectrum of tools and mechanisms displayed by Paracoccidioides to overcame phagocytosis, discusses the Trojan horse model and the immunological context in proven models or the possibility that Paracoccidioides apply this tool for dissemination to other tissues.


Assuntos
Paracoccidioides , Paracoccidioidomicose , Humanos , Neutrófilos , Fagócitos , Virulência
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...